Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | -2.85% | +0.33% | -47.07% |
Financials (USD)
Sales 2024 * | 65.38M | Sales 2025 * | 6.25M | Capitalization | 20.45M |
---|---|---|---|---|---|
Net income 2024 * | 24M | Net income 2025 * | -41M | EV / Sales 2024 * | 0.31 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.27 x |
P/E ratio 2024 * |
0.93
x | P/E ratio 2025 * |
-0.52
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.46% |
Latest transcript on MEI Pharma, Inc.
1 day | -2.85% | ||
1 week | +0.33% | ||
Current month | +0.66% | ||
1 month | -19.63% | ||
3 months | -35.77% | ||
6 months | -56.52% | ||
Current year | -47.07% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 3.07 | -2.85% | 14,114 |
24-05-08 | 3.16 | +0.96% | 2,593 |
24-05-07 | 3.13 | -2.19% | 25,158 |
24-05-06 | 3.2 | +4.58% | 15,184 |
24-05-03 | 3.06 | 0.00% | 17,147 |
Delayed Quote Nasdaq, May 09, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.07% | 20.45M | |
+23.37% | 47.02B | |
+49.67% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- MEIP Stock